Life Stem Genetics Inc. (LIFS)

Market Cap	24.58K
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	245.84M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,500
Open	0.0001
Previous Close	n/a
Day's Range	0.0001 - 0.0001
52-Week Range	0.0001 - 0.0003
Beta	0.60
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Life Stem Genetics

Life Stem Genetics Inc., a development stage company, focuses on establishing stem cell therapy based clinics worldwide. Its products and services include nutraceutical and medical supplements, and IV nutritional cocktails; stem cell banking services; stem cell treatments for degenerative conditions, hyperbaric oxygen therapy, cancer treatments, and weight loss; anti-aging stem cell therapy; anti-viral therapy; and adistem stem cell treatments for orthopedics, neurological, and lung diseases. Life Stem Genetics Inc. has a strategic collaborativ...

• Industry: Shell Companies
• Sector: Financials
• Founded: 2012
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: LIFS

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 10, 2026

Data Sources Report a data error